https://prabadinews.com/
  • October 8, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Donanemab-Azbt Demonstrated Long-Term Efficacy in Slowing Cognitive Decline

Donanemab-Azbt Demonstrated Long-Term Efficacy in Slowing Cognitive Decline

Donanemab-azbt shows sustained benefits in slowing cognitive decline in Alzheimer disease, emphasizing the value of early intervention and treatment.

administrator

Related Articles